CASP8 SNP D302H (rs1045485) Is Associated with Worse Survival in MYCN-Amplified Neuroblastoma Patients

Lack of association betweenMDM2promoter SNP309 and clinical outcome in patients with neuroblastoma

(2014) Ali Rihani et al.   PEDIATRIC BLOOD & CANCER

Th-MYCN Mice with Caspase-8 Deficiency Develop Advanced Neuroblastoma with Bone Marrow Metastasis

(2013) Tal Teitz et al.   CANCER RESEARCH

Common variation at 6q16 within HACE1 and LIN28B influences susceptibility to neuroblastoma

(2012) Sharon J Diskin et al.   NATURE GENETICS

Hallmarks of Cancer: The Next Generation

(2011) Douglas Hanahan et al.   CELL

Neuroblastoma epigenetics: From candidate gene approaches to genome-wide screenings

(2011) Anneleen Decock et al.   Epigenetics

A germline variant in the TP53 polyadenylation signal confers cancer susceptibility

(2011) Simon N Stacey et al.   NATURE GENETICS

Phenotype Restricted Genome-Wide Association Study Using a Gene-Centric Approach Identifies Three Low-Risk Neuroblastoma Susceptibility Loci

(2011) Lễ B. Nguyễn et al.   PLoS Genetics

Bioinformatics challenges for genome-wide association studies

(2010) J. H. Moore et al.   BIOINFORMATICS

Caspase-8 as a therapeutic target in cancer

(2010) Dwayne G. Stupack   CANCER LETTERS

An Illegitimate microRNA Target Site within the 3' UTR of MDM4 Affects Ovarian Cancer Progression and Chemosensitivity

(2010) J. Wynendaele et al.   CANCER RESEARCH

Neuroblastoma: Biology, Prognosis, and Treatment

(2010) Julie R. Park et al.   HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA

Integrative genomics identifies LMO1 as a neuroblastoma oncogene

(2010) Kai Wang et al.   NATURE

Recent Advances in Neuroblastoma

(2010) John M. Maris   NEW ENGLAND JOURNAL OF MEDICINE

Chemosensitivity Profiles Identify Polymorphisms in the p53 Network Genes 14-3-3  and CD44 That Affect Sarcoma Incidence and Survival

(2009) A. Vazquez et al.   CANCER RESEARCH

Escape from p53-mediated tumor surveillance in neuroblastoma: switching off the p14ARF-MDM2-p53 axis

(2009) T Van Maerken et al.   CELL DEATH AND DIFFERENTIATION

Common variations in BARD1 influence susceptibility to high-risk neuroblastoma

(2009) Mario Capasso et al.   NATURE GENETICS

Detection of CpG island hypermethylation of caspase-8 in neuroblastoma using an oligonucleotide array

(2009) Arata Kamimatsuse et al.   PEDIATRIC BLOOD & CANCER

MDM2SNP309 genotype influences survival of metastatic but not of localized neuroblastoma

(2009) Chiara Perfumo et al.   PEDIATRIC BLOOD & CANCER

Single-nucleotide Polymorphisms in the p53 Signaling Pathway

(2009) L. F. Grochola et al.   Cold Spring Harbor Perspectives in Biology

MDM2 SNP309 is associated with high grade node positive breast tumours and is in linkage disequilibrium with a novel MDM2 intron 1 polymorphism

(2008) Fiona EM Paulin et al.   BMC CANCER

Genotyping panel for assessing response to cancer chemotherapy

(2008) Zunyan Dai et al.   BMC Medical Genomics

Impact of MDM2 SNP309 genotype on progression and survival of stage 4 neuroblastoma

(2008) C. Perfumo et al.   EUROPEAN JOURNAL OF CANCER

The International Neuroblastoma Risk Group (INRG) Classification System: An INRG Task Force Report

(2008) Susan L. Cohn et al.   JOURNAL OF CLINICAL ONCOLOGY

The genetics of the p53 pathway, apoptosis and cancer therapy

(2008) Alexei Vazquez et al.   NATURE REVIEWS DRUG DISCOVERY

Chromosome 6p22 Locus Associated with Clinically Aggressive Neuroblastoma

(2008) John M. Maris et al.   NEW ENGLAND JOURNAL OF MEDICINE